<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0038">
 <label>38.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Chen</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Eckman</surname>
   <given-names>EA</given-names>
  </string-name>, 
  <string-name>
   <surname>Eckman</surname>
   <given-names>CB</given-names>
  </string-name>, 
  <string-name>
   <surname>Chen</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Eckman</surname>
   <given-names>EA</given-names>
  </string-name>, 
  <string-name>
   <surname>Eckman</surname>
   <given-names>CB</given-names>
  </string-name>. 
  <article-title>Reductions in levels of the alzheimer’s amyloid β peptide after oral administration of ginsenosides</article-title>. 
  <source>
   <italic toggle="yes">FASEB J</italic>
  </source>. 
  <year>2006</year>;
  <volume>20</volume>(
  <issue>8</issue>):
  <fpage>1269</fpage>–
  <lpage>1271</lpage>. doi:
  <pub-id pub-id-type="doi">10.1096/fj.05-5530fje</pub-id>
  <pub-id pub-id-type="pmid">16636099</pub-id>
 </mixed-citation>
</ref>
